What is polycystic ovary syndrome? Polycystic ovary syndrome (PCOS) is a common cause of infertility. Briefly, its diagnosis is based on presence of two of the following three criteria: read more
Despite remarkable advances in IVF treatment protocols, the success rates with poor responder patients remain low (a live birth rate of around 7%). Poor responders are defined as those that satisfy ... read more
The first live birth after an IVF frozen embryo transfer was in 1983. Since then, there have been hundreds and thousands of babies born the world over with frozen embryos. A third of the babies born ... read more
We use several blood tests to assess a woman's potential to respond to fertility treatment. Initial research on measuring anti-Mullerian hormone (AMH) levels, used for gauging assessing ovarian ... read more
The patient in the in vitro fertilization / IVF process who is a “poor ovarian responder” remains a challenge in clinical practice. The European Society for Human Reproduction and Embryology (ESHRE) ... read more
Given a choice, a majority of patients would prefer to take medications orally. So when it comes to progesterone, why do we prefer the intramuscular or the vaginal route? It's simple: the oral route ... read more
Anti-mullerian hormone (AMH) is the substance that is responsible for destroying the mullerian ducts (female reproductive organs) in developing male embryos... read more
Anti-mullerian hormone (AMH) levels are now routinely used clinically to assess ovarian reserve. AMH levels are believed to reflect the pool of oocytes (eggs) that remain in the ovary (ies). Low AMH ... read more
Letrozole is an oral non-steroidal aromatase inhibitor approved for the treatment of hormonally responsive breast cancer after surgery. It has been used (off-label) for ovulation induction as part of ... read more
The Ovarian Assessment Report from ReproSource Fertility Diagnostics is used by some fertility clinics—including InVia Fertility Specialists—for ovarian reserve testing in patients. According to ... read more
